Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel’s Market ...
At close: 19 September at 15:51 GMT-4 ...
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly greater proportion ...
At close: 16 September at 11:24 GMT+10 ...
At close: 3 September at 10:37 GMT-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback